Conference abstractPublished 20 Mar 2019
Formulation development and in-vitro characterization of orodispersible tablets of Piroxicam and Lidocaine HCl for use in dental pain
NovaMed Pharmaceuticals (Pvt) Ltd., Pakistan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The purpose of this research study was formulation development and in-vitro characterization of orodispersible tablets of Piroxicam and Lidocaine HCl along with the development and validation of the novel method of simultaneous estimation of both the drugs on HPLC. The aim was to develop a product that will provide immediate relief from the pain of dental origin, due to the local action of lidocaine in the mouth and also produce long-lasting analgesia by piroxicam after absorption. Orodispersible tablets of Piroxicam and Lidocaine HCl were developed by direct compression method. FTIR spectroscopy was used to study drug-drug and drugs-excipients compatibility. The FTIR spectra showed that there was no interaction between the two drugs and also between the drugs and excipients which proved that all the ingredients are compatible. The assay method for simultaneous estimation of both the drugs on HPLC was developed successfully. The developed method was also validated by following ICH guidelines.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectDentistry & Oral Health
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Muhammad Shahid Khan”